NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Total assets 2016–2024
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) total assets at each fiscal year-end, per SEC filings.
$627,000FY2024 · since FY2016: $712,000 → $627,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $627,000 | -61.4% |
| FY2023 | $1.6M | +12.6% |
| FY2022 | $1.4M | -66.8% |
| FY2021 | $4.3M | -20.9% |
| FY2020 | $5.5M | -32.0% |
| FY2019 | $8.1M | +724.9% |
| FY2018 | $979,000 | -52.4% |
| FY2017 | $2.1M | +188.9% |
| FY2016 | $712,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NYMXF financial trends
NYMXF RevenueNYMXF Net incomeNYMXF Net marginNYMXF Gross profitNYMXF Gross marginNYMXF Operating incomeNYMXF Operating marginNYMXF Operating cash flowNYMXF Free cash flowNYMXF Capital expendituresNYMXF Return on equityNYMXF Stock buybacksNYMXF Dividends paidNYMXF Total liabilitiesNYMXF Shareholders’ equityNYMXF overview →